CLEAN - Fundamental Analysis: Financial Health & Valuation
← Back to ListKey Parameters
⭐ Fundamental Rating: 3.2
✅ Positive
Clean Science & Technology demonstrates healthy profit growth with a PAT increase of 8.6% QoQ, supported by robust ROCE of 21.6%. The company's low debt-to-equity ratio and favorable PEG ratio indicate financial stability and undervaluation relative to earnings growth.
⚠️ Limitation
The significant P/E ratio of 31.1 suggests the stock is trading at a premium, potentially reflecting high future growth expectations or market sentiment. Declining profit margins (-26.1% QoQ) and negative MACD suggest potential headwinds for immediate profitability gains.
📉 Company Negative News
Recent news regarding the incorporation of a Dutch entity highlights expansion plans but doesn’t immediately translate to improved earnings. The upcoming earnings call on August 1 may reveal further details impacting investor sentiment.
📈 Company Positive News
None found
🏭 Industry
The specialty chemicals sector is experiencing steady growth driven by increasing demand from end-use industries like agrochemicals, pharmaceuticals, and paints. Competition within the industry remains intense with various global players and fluctuating raw material prices contributing to volatility.
🧾 Conclusion
Given its strong ROCE and manageable debt, a potential entry zone could be around 700 - 720 ₹, utilizing a conservative estimate of future growth based on current trends. For long-term holding, focusing on the company’s expansion into new chemical segments and sustained profitability is key; expect capital appreciation over 3-5 years if the company continues to demonstrate its operational efficiency. Overall, Clean Science presents a moderately attractive investment opportunity with reasonable risk tolerance.